Literature DB >> 30294857

Assessment of plasma lactate and core-peripheral temperature gradient in association with stages of naturally occurring myxomatous mitral valve disease in dogs.

Felipe B Soares1,2, Gláucia B Pereira-Neto1,2, Rodrigo C Rabelo3.   

Abstract

OBJECTIVE: To evaluate plasma lactate concentrations and core-peripheral temperature gradients as perfusion parameters in dogs with heart failure caused by myxomatous mitral valve disease (MMVD) and to determine whether the above perfusion parameters are correlated with disease stages.
DESIGN: Prospective observational study.
SETTING: University teaching hospital. ANIMALS: After excluding 129 dogs because of exclusion criteria, 7 dogs with heart failure classified as stage B2 and 10 dogs classified as stage C according to the American Heart Association (AHA)/American College of Cardiology (ACC) were included in the study. Six dogs without MMVD were evaluated as the control group.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among the evaluated parameters, the plasma lactate concentrations were increased in stage C (median 3.70 mmol/L [33.3 mg/dL], interquartile range (IQR) 0.72 mmol/L [6.5 mg/dL]) compared with those in the control (median 2.80 mmol/L [25.2 mg/dL], IQR 0.8 mmol/L [7.2 mg/dL]; P = 0.024) and stage B2 groups (median 2.70 mmol/L [24.3 mg/dL], IQR 1.8 mmol/L [16.2 mg/dL]; P = 0.045). Significant differences were not observed in the core-peripheral temperature gradients among the control, stage B2, and stage C dogs.
CONCLUSIONS: Dogs with structural heart disease as a result of MMVD may have occult tissue hypoperfusion in stage C that is demonstrated by hyperlactatemia. © Veterinary Emergency and Critical Care Society 2018.

Entities:  

Keywords:  cryptic shock; heart failure; hyperlactatemia; lactate; temperature gradients

Mesh:

Substances:

Year:  2018        PMID: 30294857     DOI: 10.1111/vec.12771

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  3 in total

Review 1.  Advances in the diagnosis of acute pancreatitis in dogs.

Authors:  Harry Cridge; David C Twedt; Angela J Marolf; Leslie C Sharkey; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2021-11-09       Impact factor: 3.333

2.  Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.

Authors:  Adrian Boswood; Sonya G Gordon; Jens Häggström; Martin Vanselow; Gerhard Wess; Rebecca L Stepien; Mark A Oyama; Bruce W Keene; John Bonagura; Kristin A MacDonald; Mark Patteson; Sarah Smith; Philip R Fox; Karen Sanderson; Richard Woolley; Viktor Szatmári; Pierre Menaut; Whitney M Church; M Lynne O'Sullivan; Jean-Philippe Jaudon; Jan-Gerd Kresken; John Rush; Kirstie A Barrett; Steven L Rosenthal; Ashley B Saunders; Ingrid Ljungvall; Michael Deinert; Eric Bomassi; Amara H Estrada; Maria J Fernandez Del Palacio; N Sydney Moise; Jonathan A Abbott; Yoko Fujii; Alan Spier; Michael W Luethy; Roberto A Santilli; Masami Uechi; Anna Tidholm; Christoph Schummer; Philip Watson
Journal:  J Vet Intern Med       Date:  2020-03-22       Impact factor: 3.333

3.  Left ventricular myocardial remodeling in dogs with mitral valve endocardiosis.

Authors:  Yury A Vatnikov; Andrey A Rudenko; Boris V Usha; Evgeny V Kulikov; Elena A Notina; Irina A Bykova; Nadiya I Khairova; Irina V Bondareva; Victor N Grishin; Andrey N Zharov
Journal:  Vet World       Date:  2020-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.